Works by Rosenheck, Hanna
Results: 2
Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56674-4
- By:
- Publication type:
- Article
Prognostic immune markers in esophageal cancer patients managed with trimodal therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2025, v. 74, n. 2, p. 1, doi. 10.1007/s00262-024-03891-3
- By:
- Publication type:
- Article